Portfolio Design Labs, LLC Astrazeneca PLC Transaction History
Portfolio Design Labs, LLC
- $485 Billion
- Q1 2025
A detailed history of Portfolio Design Labs, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Portfolio Design Labs, LLC holds 2,757 shares of AZN stock, worth $195,664. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,757
Previous 3,376
18.34%
Holding current value
$195,664
Previous $221 Million
8.39%
% of portfolio
0.04%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.05 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.89 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.53 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.26 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...